We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+15.09%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.33B
AUM Growth
+$519M
Cap. Flow
+$261M
Cap. Flow %
11.2%
Top 10 Hldgs %
31.18%
Holding
1,170
New
202
Increased
753
Reduced
172
Closed
43

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$13.4M
2
TSLA icon
Tesla
TSLA
+$13.2M
3
MSFT icon
Microsoft
MSFT
+$5.94M
4
AAPL icon
Apple
AAPL
+$5.64M
5
NVDA icon
NVIDIA
NVDA
+$5.32M

Sector Composition

Rank Sector Weight
1 Technology 39.75%
2 Healthcare 13.35%
3 Consumer Discretionary 11.99%
4 Communication Services 9.24%
5 Energy 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMRN icon
251
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.47M 0.06%
15,244
-963
-6% -$85.2K
SNAP icon
252
Snap
SNAP
$7.32B
$1.46M 0.06%
86,498
-23,157
-21% -$284K
ZTO icon
253
ZTO Express
ZTO
$18.2B
$1.44M 0.06%
67,730
+10,286
+18% +$234K
CRNX icon
254
Crinetics Pharmaceuticals
CRNX
$8.86B
$1.43M 0.06%
40,134
+6,308
+19% +$193K
LMT icon
255
Lockheed Martin
LMT
$134B
$1.42M 0.06%
3,141
+554
+21% +$245K
SNDX icon
256
Syndax Pharmaceuticals
SNDX
$1.84B
$1.41M 0.06%
65,182
+17,140
+36% +$263K
DE icon
257
Deere & Co
DE
$170B
$1.41M 0.06%
3,517
+361
+11% +$136K
ZM icon
258
Zoom
ZM
$25.8B
$1.4M 0.06%
19,432
-15,590
-45% -$1.03M
TWST icon
259
Twist Bioscience
TWST
$5.62B
$1.39M 0.06%
37,614
-19,241
-34% -$445K
ARDX icon
260
Ardelyx
ARDX
$1.24B
$1.38M 0.06%
222,648
+37,885
+21% +$170K
OKTA icon
261
Okta
OKTA
$24.1B
$1.38M 0.06%
15,248
+1,285
+9% +$98K
MMM icon
262
3M
MMM
$89B
$1.38M 0.06%
15,082
+2,373
+19% +$190K
CRSP icon
263
CRISPR Therapeutics
CRSP
$4.58B
$1.37M 0.06%
21,951
-7,317
-25% -$404K
IRWD icon
264
Ironwood Pharmaceuticals
IRWD
$611M
$1.37M 0.06%
119,484
-31,795
-21% -$315K
MTCH icon
265
Match Group
MTCH
$8.84B
$1.36M 0.06%
37,334
+5,923
+19% +$200K
BSX icon
266
Boston Scientific
BSX
$65.8B
$1.36M 0.06%
23,521
+945
+4% +$50.4K
APLS
267
DELISTED
Apellis Pharmaceuticals
APLS
$1.35M 0.06%
22,558
-12,595
-36% -$639K
CMG icon
268
Chipotle Mexican Grill
CMG
$40.8B
$1.34M 0.06%
29,250
+1,350
+5% +$56.2K
PBR icon
269
Petrobras
PBR
$121B
$1.33M 0.06%
83,460
+5,554
+7% +$85.1K
CB icon
270
Chubb
CB
$140B
$1.33M 0.06%
5,890
+1,195
+25% +$261K
ECL icon
271
Ecolab
ECL
$75.6B
$1.32M 0.06%
6,665
-9
-0.1% -$1.62K
DOW icon
272
Dow Inc
DOW
$21.6B
$1.31M 0.06%
23,973
+1,161
+5% +$59.3K
DKNG icon
273
DraftKings
DKNG
$11.4B
$1.3M 0.06%
+37,008
New +$1.24M
DVAX
274
DELISTED
Dynavax Technologies
DVAX
$1.3M 0.06%
92,991
+7,460
+9% +$104K
DOCU
275
DocuSign
DOCU
$9.63B
$1.3M 0.06%
21,867
+1,035
+5% +$47.5K

Similar funds

Profund Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Profund Advisors held 1,170 positions worth $2.33B, up 29% from $1.81B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Profund Advisors deployed $261M of net new capital in Q4 2023, opening 202 new positions and adding to 753 existing holdings. Its largest new stake was Coca-Cola Europacific Partners: 35,352 shares worth $2.36M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was eBay, an estimated $1.3M trimmed.

  • Profund Advisors's largest Q4 2023 buy was Coca-Cola Europacific Partners: 35,352 shares worth $2.36M.
  • Profund Advisors added most to Broadcom in Q4 2023, an estimated $13.4M increase.
  • Profund Advisors's biggest Q4 2023 reduction was eBay, cutting an estimated $1.3M.
  • Profund Advisors fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $4.04M.
  • Profund Advisors's ten largest holdings make up 31% of its $2.33B portfolio in Q4 2023.
  • Profund Advisors opened 202 new positions and closed 43 in Q4 2023.
  • Profund Advisors's portfolio value rose 29% quarter-over-quarter to $2.33B.

Based on Profund Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.